movement on the hcv front, page-18

Good point Hoyland.

"Drug companies waiting for a decision from the Food and Drug Administration could also see delays. The FDA said it would continue "limited activities" related to programs that are paid for by user fees from drug approval applications."

Source - http://www.reuters.com/article/2013/09/29/us-usa-fiscal-factbox-idUSBRE98S0JX20130929

I guess we will find out whether they have been able to broach a deal or not. My guess is, they will strike one last minute.